Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2014, Article ID 293063, 5 pages
http://dx.doi.org/10.1155/2014/293063
Case Report

State of Oral Mucosa as an Additional Symptom in the Course of Primary Amyloidosis and Multiple Myeloma Disease

1Department of Oral Medicine and Periodontal Diseases, Medical University of Warsaw, ul. Miodowa 18, 00-246 Warsaw, Poland
2Department of Hematology, University Hospital in Cracow, ul. Kopernika 17, 31-501 Cracow, Poland
3Department and Clinic of Haematology, Oncology and Internal Medicine, Medical University of Warsaw, ul. Banach 1A, 02-097 Warsaw, Poland

Received 23 February 2014; Accepted 22 May 2014; Published 9 June 2014

Academic Editor: Mark E. Shaffrey

Copyright © 2014 Maciej R. Czerniuk et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. S. Tonetti, “Periodontitis and risk for atherosclerosis: an update on intervention trials,” Journal of Clinical Periodontology, vol. 36, no. 10, pp. 15–19, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Offenbacher, S. P. Barros, R. E. Singer, K. Moss, R. C. Williams, and J. D. Beck, “Periodontal disease at the biofilm-gingival interface,” Journal of Periodontology, vol. 78, no. 10, pp. 1911–1925, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Offenbacher, S. P. Barros, and J. D. Beck, “Rethinking periodontal inflammation,” Journal of Periodontology, vol. 79, no. 8, pp. 1577–1584, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. R. A. Seymour, “Is gum disease killing your patient?” British Dental Journal, vol. 206, no. 10, pp. 551–552, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. T. E. van Dyke, “Control of inflammation and periodontitis,” Periodontology 2000, vol. 45, no. 1, pp. 158–166, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Badros, D. Weikel, A. Salama et al., “Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors,” Journal of Clinical Oncology, vol. 24, no. 6, pp. 945–952, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. S. B. Woo, J. W. Hellstein, and J. R. Kalmar, “Bisphosphonates and osteonecrosis of the jaws,” Annals of Internal Medicine, vol. 144, no. 3, pp. 753–761, Erratum to “Bisphosphonates and osteonecrosis of the jaws”, Annals of Internal Medicine, vol. 145, p. 235, 2006. View at Scopus
  8. R. A. Kyle and S. V. Rajkumar, “Drug therapy: multiple myeloma,” The New England Journal of Medicine, vol. 351, no. 18, pp. 1860–1873, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Ise and T. Takagi, “Bone lesion in multiple myeloma,” Nippon Rinsho, vol. 65, no. 12, pp. 2224–2228, 2007. View at Google Scholar · View at Scopus
  10. F. S. O'Ryan, S. Khoury, W. Liao et al., “Intravenous bisphosphonate-related osteonecrosis of the Jaw: bone scintigraphy as an early indicator,” Journal of Oral and Maxillofacial Surgery, vol. 67, no. 7, pp. 1363–1372, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. C. A. Migliorati, M. A. Siegel, and L. S. Elting, “Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment,” Lancet Oncology, vol. 7, no. 6, pp. 508–514, Erratum to “Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment”, Lancet Oncology, vol. 7, p. 533, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Dimopoulos, A. Spencer, M. Attal et al., “Multiple myeloma (010) study investigators,” The New England Journal of Medicine, vol. 357, pp. 2123–2132, 2007, Erratum to “Multiple myeloma (010) study investigators”, The New England Journal of Medicine, vol.361, p. 544, 2009. View at Publisher · View at Google Scholar
  13. A. Özet, Ş. Güran, and M. Beksac, “Familial multiple myeloma associated with disorders of chronic inflammation: first report from Turkey,” Clinical Lymphoma and Myeloma, vol. 8, no. 4, pp. 246–248, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. C. R. D. A. Estrela, F. C. Pimenta, A. H. G. de Alencar, L. F. N. Ruiz, and C. Estrela, “Detection of selected bacterial species in intraoral sites of patients with chronic periodontitis using multiplex polymerase chain reaction,” Journal of Applied Oral Science, vol. 18, no. 4, pp. 426–431, 2010. View at Google Scholar · View at Scopus
  15. M. R. Czerniuk and A. Gieorgijewska, “Zmiany na błonie śluzowej jamy ustnej w przebiegu choroby ogólnoustrojowej—na co należy zwrócić uwagę? [Changes in oral mucosa during a systemic disease—what to pay attention to?],” Kardiologia Po Dyplomie, vol. 9, no. 5, pp. 65–70, 2010. View at Google Scholar
  16. L. Junquera, L. Gallego, P. Cuesta, A. Pelaz, and J. C. de Vicente, “Clinical experiences with bisphosphonate-associated osteonecrosis of the jaws: analysis of 21 cases,” American Journal of Otolaryngology: Head and Neck Medicine and Surgery, vol. 30, no. 6, pp. 390–395, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Ferlito, C. Liardo, and S. Puzzo, “Dental extractions in patient treated with intravenous bisphosphonates and risk of osteonecrosis of jaws: presentation of a preventive protocol and case series,” Minerva Stomatologica, vol. 59, no. 11-12, pp. 593–601, 2010. View at Google Scholar · View at Scopus
  18. P. J. Dhanrajani and S. A. Abdulkarim, “Multiple myeloma presenting as a periapical lesion in the mandible,” Indian Journal of Dental Research, vol. 8, no. 2, pp. 58–61, 1997. View at Google Scholar · View at Scopus
  19. M. Kraj, R. Pogłód, S. Maj, and K. Owczarska, “The incidence of jaw osteonecrosis in multiple myeloma patients treated with bisphosphonates,” Acta Poloniae Pharmaceutica, vol. 63, no. 5, pp. 450–452, 2006. View at Google Scholar · View at Scopus
  20. M. Kraj, R. Pogłód, S. Maj, J. Pawlikowski, U. Sokołowska, and J. Szczepanik, “Comparative evaluation of safety and efficacy of pamidronate and zoledronic acid in multiple myeloma patients (single cancer center experience),” Acta Poloniae Pharmaceutica, vol. 59, no. 6, pp. 478–482, 2002. View at Google Scholar · View at Scopus
  21. M. Q. Lacy, A. Dispenzieri, M. A. Gertz et al., “Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma,” Mayo Clinic Proceedings, vol. 81, no. 8, pp. 1047–1053, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. J. F. San Miguel, R. Schlag, N. K. Khuageva et al., “Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma,” The New England Journal of Medicine, vol. 359, no. 9, pp. 906–917, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. M. S. Tonetti, N. P. Lang, P. Cortellini et al., “Effects of a single topical doxycycline administration adjunctive to mechanical debridement in patients with persistent/recurrent periodontitis but acceptable oral hygiene during supportive periodontal therapy,” Journal of Clinical Periodontology, vol. 39, no. 5, pp. 475–482, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. É. del Peloso Ribeiro, S. Bittencourt, E. A. Sallum, F. H. Nociti Jr., R. B. Gonçalves, and M. Z. Casati, “Periodontal debridement as a therapeutic approach for severe chronic periodontitis: a clinical, microbiological and immunological study,” Journal of Clinical Periodontology, vol. 35, no. 9, pp. 789–798, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. B. G. M. Durie, “Role of new treatment approaches in defining treatment goals in multiple myeloma—the ultimate goal is extended survival,” Cancer Treatment Reviews, vol. 36, no. 2, pp. S18–S23, 2010. View at Publisher · View at Google Scholar · View at Scopus